![](/img/cover-not-exists.png)
Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer
Musa, Fernanda, Pothuri, Bhavana, Blank, Stephanie V., Ling, Huichung T., Speyer, James L., Curtin, John, Boyd, Leslie, Li, Xiaochun, Goldberg, Judith D., Muggia, Franco, Tiersten, AmyVolume:
144
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2016.11.043
Date:
February, 2017
File:
PDF, 530 KB
english, 2017